Catch up with healthcare and wellness news from the Middle East

Provided by AGP

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on May 13, 2026

Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗,已為首位患者完成給藥
InnoCare Announce First Subject Dosed in Phase 1 Clinical Trial of ICP-054, a Novel Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
 Dyne Therapeutics to Participate in Upcoming Investor Conferences
Pyxis Oncology to Participate in Upcoming Investor Conferences
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
Palvella Therapeutics Announces Uplisting to the Nasdaq Global Market
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
Altimmune Announces First Quarter 2026 Financial Results and Business Update
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
Ocugen to Participate in Upcoming May Scientific and Investor Conferences
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline

Share us

on your social networks:

Sign up for:

The Middle East Health Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.